Evidence map›Paper›PMID 27454290›Full record

ArticleThe Journal of clinical investigation2016

p53 coordinates decidual sestrin 2/AMPK/mTORC1 signaling to govern parturition timing.

Wenbo Deng, Jeeyeon Cha, Jia Yuan, Hirofumi Haraguchi, Amanda Bartos, Emma Leishman, Benoit Viollet, Heather B Bradshaw, Yasushi Hirota, Sudhansu K Dey

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Regulation of placental development and function by ubiquitination.Molecular medicine (Cambridge, Mass.) · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. CompoundAnimal nutrition (Zhongguo xu mu shou yi xue hui) · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Wenbo Deng
Jeeyeon Cha
Jia Yuan
Hirofumi Haraguchi
Amanda Bartos
Emma Leishman
Benoit Viollet
Heather B Bradshaw
Yasushi Hirota
Sudhansu K Dey
Cincinnati Children's Hospital Medical Center · USIndiana University Bloomington · USInserm · FRThe University of Tokyo · JP

Funding

Molecular signaling in uterine receptivity to implantationR01HD068524 · NICHD · CINCINNATI CHILDRENS HOSP MED CTR · PI Xiaofei Sun · 2011 to 2026
$5.3M
Endocannabinoid Signaling During Early PregnancyR37DA006668 · NIDA · VANDERBILT UNIVERSITY · PI DEY, SUDHANSU K · 2003 to 2012
$3.8M
MARIJUANA EFFECTS ON EARLY PREGNANCYR01DA006668 · NIDA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DEY, SUDHANSU K · 1990 to 2019
$2.1M
Premature Uterine Ageing and Preterm DeliveryF30AG040858 · NIA · CINCINNATI CHILDRENS HOSP MED CTR · PI CHA, JEEYEON · 2011 to 2014
$184k
NIA NIH HHS F30 AG040858NICHD NIH HHS R01 HD068524NIDA NIH HHS R01 DA006668NIDA NIH HHS R37 DA006668
6 · The paper itself

Abstract

Inflammation and oxidative stress are known risk factors for preterm birth (PTB); however, the mechanisms and pathways that influence this condition are not fully described. Previously, we showed that mTORC1 signaling is increased in mice harboring a uterine-specific deletion of transformation-related protein 53 (p53d/d mice), which exhibit premature decidual senescence that triggers spontaneous and inflammation-induced PTB. Treatment with the mTORC1 inhibitor rapamycin reduced the incidence of PTB in the p53d/d mice. Decidual senescence with heightened mTORC1 signaling is also a signature of human PTB. Here, we have identified an underlying mechanism for PTB and a potential therapeutic strategy for treating the condition. Treatment of pregnant p53d/d mice with either the antidiabetic drug metformin or the antioxidant resveratrol activated AMPK signaling and inhibited mTORC1 signaling in decidual cells. Both metformin and resveratrol protected against spontaneous and inflammation-induced PTB in p53d/d females. Using multiple approaches, we determined that p53 interacts with sestrins to coordinate an inverse relationship between AMPK and mTORC1 signaling that determines parturition timing. This signature was also observed in human decidual cells. Together, these results reveal that p53-dependent coordination of AMPK and mTORC1 signaling controls parturition timing and suggest that metformin and resveratrol have therapeutic potential to prevent PTB.

Indexed as

AMP-Activated Protein KinasesAnimalsAntioxidantsBinding SitesCellular SenescenceDeciduaFemaleHumansInflammationMechanistic Target of Rapamycin Complex 1MiceMice, TransgenicMultiprotein ComplexesNuclear ProteinsOxidative StressParturitionAMP-Activated Protein KinasesAntioxidantsMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesNuclear ProteinsPeroxidasesSESN2 protein, humanSesn2 protein, mouseSestrinsTOR Serine-Threonine KinasesTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID27454290
PMCPMC4966330
OpenAlexW2485481679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.